---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-26-000015"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:28:12.021036+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Indivior issues $500M 0.625% convertible notes due 2031; repays existing debt

## Summary
- $500M principal of 0.625% Convertible Senior Notes due March 15, 2031 issued; initial purchasers' option fully exercised for additional $50M.
- Initial conversion price of ~$41.66 per share (35% premium over March 12 close); max ~16.2M shares issuable upon conversion.
- Proceeds used to prepay all outstanding principal, interest, and fees under November 2024 Note Purchase Agreement; that agreement terminated.
- Notes redeemable at Indivior's option after March 20, 2029 if stock exceeds 130% of conversion price for 20 of 30 trading days.
- Notes are senior unsecured, structurally subordinated to subsidiary liabilities; interest payable semi-annually on March 15 and September 15.

## SEC filing metadata
- accession: 0001625297-26-000015
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000015/0001625297-26-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000015/indv-20260317.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-26-000015
- JSON: https://secwatch.observer/filing/0001625297-26-000015.json
- Plain text: https://secwatch.observer/filing/0001625297-26-000015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.